| # | Query Results | |
| S1 | (MH “Diabetes Mellitus, Type 1+”) | 17,153 |
| S2 | ((diabet* N3 (typ* 1 or typ* i or type1 or typei or typ* one or brittl* or juvenil* or pediatric or paediatric or early or keto* or labil* or acidos* or autoimmun* or auto immun* or sudden onset or young onset)) or (insulin* N2 depend*) or insulindepend* or dm1 or dm 1 or dmt1 or dm t1 or t1dm or t1 dm or t1d or iddm) | 26,773 |
| S3 | (MH “Diabetic Ketoacidosis”) | 1,653 |
| S4 | (ketoacidosis or acidoketosis or keto acidosis or ketoacidemia or ketosis) | 2,266 |
| S5 | (MH “Hypoglycemia”) | 6,679 |
| S6 | (MH “Diabetes Mellitus”) | 46,256 |
| S7 | S5 AND S6 | 1,343 |
| S8 | ((hypoglyc#em* or ((low or lower or decreas* or deficien* or insufficien* or reduce* or reduction* or fluctuat* or fallen or falling or threshold or safe) N3 (glucose* or sugar* or hba1c or hb a1 or hba1 or a1c or h#emoglob* or glycoh#emoglob*))) N5 (diabet* or IDDM or DM)) | 4,756 |
| S9 | S1 OR S2 OR S3 OR S4 OR S7 OR S8 | 31,012 |
| S10 | (MH “Blood Glucose Self-Monitoring”) | 2,778 |
| S11 | (continu* or uninterrupt* or ongoing or looped or interminable) | 272,487 |
| S12 | S10 AND S11 | 537 |
| S13 | ((continu* or uninterrupt* or ongoing or looped or interminable) N4 (blood glucose or blood sugar*) N2 (self monitor* or home monitor*)) | 27 |
| S14 | ((continu* or uninterrupt* or ongoing or looped or interminable) N4 SMBG) | 26 |
| S15 | (CGM or CGMS or continuous glucose monitor* or continuous glucose sensor*) | 1,179 |
| S16 | ((medtronic N3 (paradigm* or glucose monitor* or glucose sensor* or CGM or insulin pump* or LGS or 630G)) or veo or veotm or minimed or dexcom or g4 platinum or g5 platinum) | 205 |
| S17 | ((flash or novel) N2 glucose N2 (monitor* or sensor or sensing)) | 17 |
| S18 | ((integrat* N2 (pump or pumps or infusion*)) or (sensor N3 (pump or pumps or therap* or infusion*)) or (sensor augment* N2 pump*) or low glucose suspend*) | 199 |
| S19 | (closed loop N2 (pump* or deliver* or infus* or therap* or treatment* or system* or sensor* or control* or monitor* or hybrid*)) | 393 |
| S20 | (artificial N3 (pancreas or beta cell*)) | 197 |
| S21 | S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 | 1,974 |
| S22 | S9 AND S21 | 1,034 |
| S23 | (MH “Economics”) | 10,992 |
| S24 | (MH “Economic Aspects of Illness”) | 6,584 |
| S25 | (MH “Economic Value of Life”) | 518 |
| S26 | MH “Economics, Dental” | 104 |
| S27 | MH “Economics, Pharmaceutical” | 1,760 |
| S28 | MW “ec” | 140,414 |
| S29 | (econom* or price or prices or pricing or priced or discount* or expenditure* or budget* or pharmacoeconomic* or pharmaco-economic*) | 210,045 |
| S30 | (MH “Costs and Cost Analysis+”) | 83,883 |
| S31 | TI cost* | 39,344 |
| S32 | (cost effective*) | 26,695 |
| S33 | AB (cost* N2 (util* or efficacy* or benefit* or minimi* or analy* or saving* or estimate* or allocation or control or sharing or instrument* or technolog*)) | 17,578 |
| S34 | (decision N1 (tree* or analy* or model*)) | 4,861 |
| S35 | (markov or markow or monte carlo) | 3,005 |
| S36 | (MH “Quality-Adjusted Life Years”) | 2,571 |
| S37 | (QOLY or QOLYs or HRQOL or HRQOLs or QALY or QALYs or QALE or QALEs) | 5,656 |
| S38 | ((adjusted N1 (quality or life)) or (willing* N2 pay) or sensitivity analys?s) | 10,819 |
| S39 | S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 | 279,380 |
| S40 | S22 AND S39 | 66 |
| S41 | S22 AND S39 | |
| Limiters - English Language | 66 | |
| S42 | S22 AND S39 | |
| Limiters - Published Date: 20100101-20171231; English Language | 44 |